Regience

  • HOME >
  • News >
  • Advance into Clinical stage

Advance into Clinical stage

2014/12/26

Advance into Clinical stage

Novel manufacturing facility for clinical application is settled in Kobe Port Island

Regience K.K. (hereafter, Regience) settles the manufacturing facility in Kobe Port Island

(Kobe Biomedical Innovation Cluster), which enable us to manufacture the regenerative medical products in accordance with GMP regulations.…To be continued.

PAGE TOP